TrialBlood advances2022

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.

Trine Alma Knudsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.